The African Cancer Atlas: Expanding Precision Oncology Through Diversity

Who You Miss Matters. The African Cancer Atlas: Leveraging African Data to Diversify Precision Oncology The African Cancer Atlas: Expanding Precision Oncology Through Diversity Africa has the world’s highest age-adjusted cancer mortality rates, with incidence projected to double by 2040, yet African populations remain understudied in cancer genomics research. This webinar explores how Yemaachi Biotech is addressing this gap through The African Cancer Atlas (TACA), pan-African oncology network across 9 countries, is a globally relevant initiative building the world’s most diverse cancer genome database. This webinar will highlight insights from population-specific cancer genomics, including novel driver mutations, structural variants, and epigenetic signatures, and demonstrate how Oxford Nanopore Technologies enhances discovery through scalable sequencing solutions. Key learnings • Importance of inclusive genomics for precision medicine • The impact of structural and epigenetic variation in cancer • The potential to leapfrog cancer care through integrated NGS in African clinical settings Africa has some of the world’s highest cancer mortality rates with incidence projected to double by 2040, yet African populations remain underrepresented in cancer genomics. This gap limits discovery of clinically relevant variants and slows progress toward equitable precision oncology. This webinar will showcase how The African Cancer Atlas, a pan-African network across nine countries, is generating population-specific genomic insights to change that trajectory. Attendees will learn how large-scale cancer genome data combined with scalable sequencing approaches can expand biological understanding and support more inclusive next-generation cancer research and care.